Oslo, Norway, 24 June 2020
Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the extraordinary general meeting held on 24 June 2020. All matters were resolved as proposed in the call for the extraordinary general meeting.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachment
